Secondary endpoints were procedural performance assessed by quantitative angiography and intravascular ultrasound ; composite clinical endpoints based on death , myocardial infarction , and coronary revascularisation ; device and procedural success ; and angina status assessed by the Seattle Angina Questionnaire and exercise testing at 6 and 12 months .